The purpose of this study is to evaluate the effect of BMS-986278 on the cardiac repolarization in healthy participants.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from baseline Fridericia's corrected QT interval (QTcF) (ΔQTcF)
Timeframe: Up to Day 13
Placebo-corrected change from baseline QTcF (ΔΔQTcF)
Timeframe: Up to Day 13
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com